Literature DB >> 9840529

Long term prognosis after hepatectomy for hepatocellular carcinoma: a survival analysis of 204 consecutive patients.

H Lau1, S T Fan, I O Ng, J Wong.   

Abstract

BACKGROUND: Intrahepatic recurrence continues to be the main cause of late death among hepatocellular carcinoma patients after hepatic resection. The aims of the current study were to identify the prognostic factors affecting long term survival and to evaluate the clinical value of pTNM classification as a prognostic factor for these patients. The identification of significant prognostic factors plays an important role in the selection of patients for postoperative adjuvant therapy and counseling.
METHODS: From January 1989 to August 1995, 204 consecutive patients underwent hepatectomy for hepatocellular carcinoma. The overall cumulative and disease free survival rates for these patients were analyzed. Univariate and multivariate analyses of 16 clinicopathologic factors, including factors associated with pTNM classification, were performed to determine the significant prognostic factors.
RESULTS: The median periods of overall cumulative survival and disease free survival were 35 months and 12.4 months, respectively. By univariate analysis, all factors associated with tumor (T) classification, namely, tumor size, vascular invasion, the number of tumor nodules, and tumor localization, were correlated with survival. By Cox regression analysis, preoperative indocyanine green retention value at 15 minutes, tumor size, and number of tumor nodules were independent prognostic factors of long term survival, whereas the number of tumor nodules, tumor size, and venous permeation were the most powerful predictors of tumor recurrence. The cumulative 5-year survival rates for patients with Stages I, II, III, and IVA tumors were 72%, 55%, 34%, and 8%, respectively. Significant differences in cumulative survival curves were observed among the categories of pTNM classification.
CONCLUSIONS: The results of this study showed that pTNM classification correlated well with postoperative survival. Preoperative evaluation of hepatic functional reserve with an indocyanine green clearance test plays an important role in determining the long term prognoses of patients with hepatocellular carcinoma.

Entities:  

Mesh:

Year:  1998        PMID: 9840529

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  25 in total

1.  Hepatocellular carcinoma screening in a hepatitis B virus-infected Korean population.

Authors:  Seung Ha Park; Nae Yun Heo; Jong Ha Park; Tae Oh Kim; Sung Yeun Yang; Hyun Kuk Kim; Young Soo Moon; Chang Hoon Kim; Ki Tae Suk; Dong Joon Kim; Heon Young Lee
Journal:  Dig Dis Sci       Date:  2012-06-23       Impact factor: 3.199

2.  Preoperative galactose elimination capacity predicts complications and survival after hepatic resection.

Authors:  Claudio A Redaelli; Jean-François Dufour; Markus Wagner; Martin Schilling; Jürg Hüsler; Lukas Krähenbühl; Markus W Büchler; Jürg Reichen
Journal:  Ann Surg       Date:  2002-01       Impact factor: 12.969

3.  Overexpression of metastasis-associated in colon cancer 1 predicts a poor outcome of hepatitis B virus-related hepatocellular carcinoma.

Authors:  Jian-Hui Qu; Xiu-Juan Chang; Yin-Ying Lu; Wen-Lin Bai; Yan Chen; Lin Zhou; Zhen Zeng; Chun-Ping Wang; Lin-Jing An; Li-Yan Hao; Gui-Lin Xu; Xu-Dong Gao; Min Lou; Ji-Yun Lv; Yong-Ping Yang
Journal:  World J Gastroenterol       Date:  2012-06-21       Impact factor: 5.742

4.  Clinicopathological Characteristics of Hepatocellular Carcinoma with Microscopic Portal Venous Invasion and the Role of Anatomical Liver Resection in These Cases.

Authors:  Shingo Shimada; Toshiya Kamiyama; Hideki Yokoo; Tatsuya Orimo; Kenji Wakayama; Takahiro Einama; Tatsuhiko Kakisaka; Hirofumi Kamachi; Akinobu Taketomi
Journal:  World J Surg       Date:  2017-08       Impact factor: 3.352

5.  Partial hepatectomy with wide versus narrow resection margin for solitary hepatocellular carcinoma: a prospective randomized trial.

Authors:  Ming Shi; Rong-Ping Guo; Xiao-Jun Lin; Ya-Qi Zhang; Min-Shan Chen; Chang-Qing Zhang; Wan Yee Lau; Jin-Qing Li
Journal:  Ann Surg       Date:  2007-01       Impact factor: 12.969

6.  The hippurate ratio as an indicator of functional hepatic reserve for resection of hepatocellular carcinoma in cirrhotic patients.

Authors:  A W Hemming; S Gallinger; P D Greig; M S Cattral; B Langer; B R Taylor; Z Verjee; E Giesbrecht; Y Nakamachi; K N Furuya
Journal:  J Gastrointest Surg       Date:  2001 May-Jun       Impact factor: 3.452

7.  Differentiating the impact of anatomic and non-anatomic liver resection on early recurrence in patients with Hepatocellular Carcinoma.

Authors:  Karim M Eltawil; Mark Kidd; Francesco Giovinazzo; Ahmed H Helmy; Ronald R Salem
Journal:  World J Surg Oncol       Date:  2010-05-24       Impact factor: 2.754

8.  Prediction of postoperative hepatic insufficiency by liver stiffness measurement (FibroScan((R))) before curative resection of hepatocellular carcinoma: a pilot study.

Authors:  Seung Up Kim; Sang Hoon Ahn; Jun Yong Park; Do Young Kim; Chae Yoon Chon; Jin Sub Choi; Kyung Sik Kim; Kwang-Hyub Han
Journal:  Hepatol Int       Date:  2008-09-09       Impact factor: 6.047

9.  Prognostic impact of Fas ligand on hepatocellular carcinoma after hepatectomy.

Authors:  Wei-Chen Lee; Ming-Chin Yu; Miin-Fu Chen
Journal:  World J Surg       Date:  2004-08-03       Impact factor: 3.352

10.  New indication for reduction surgery in patients with advanced hepatocellular carcinoma with major vascular involvement.

Authors:  Naoto Gotohda; Taira Kinoshita; Masaru Konishi; Toshio Nakagohri; Shinichiro Takahashi; Junji Furuse; Hiroshi Ishii; Masahiro Yoshino
Journal:  World J Surg       Date:  2006-03       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.